| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |